Arginase 1 contributes to diminished coronary arteriolar dilation in patients with diabetes.
Arginase 1, via competing with nitric oxide (NO) synthase for the substrate L-arginine, may interfere with NO-mediated vascular responses. We tested the hypothesis that arginase 1 contributes to coronary vasomotor dysfunction in patients with diabetes mellitus (DM). Coronary arterioles were dissecte...
Prif Awduron: | Beleznai, T, Feher, A, Spielvogel, D, Lansman, S, Bagi, Z |
---|---|
Fformat: | Journal article |
Iaith: | English |
Cyhoeddwyd: |
2011
|
Eitemau Tebyg
-
Overexpression of Arginase I Leads to Diminished Acetylcholine-Induced Coronary Arteriolar Dilation in Patients with Type 2 Diabetes Mellitus
gan: Bagi, Z, et al.
Cyhoeddwyd: (2009) -
Upregulation of Arginase I Reduces Nitric Oxide-mediated Coronary Arteriolar Dilation in Patients With Type 2 Diabetes
gan: Bagi, Z, et al.
Cyhoeddwyd: (2009) -
Preserved coronary arteriolar dilatation in patients with type 2 diabetes mellitus: implications for reactive oxygen species.
gan: Bagi, Z, et al.
Cyhoeddwyd: (2009) -
Caveolin-1 limits the contribution of BK(Ca) channel to EDHF-mediated arteriolar dilation: implications in diet-induced obesity.
gan: Feher, A, et al.
Cyhoeddwyd: (2010) -
Activation of hexosamine pathway impairs nitric oxide (NO)-dependent arteriolar dilations by increased protein O-GlcNAcylation.
gan: Beleznai, T, et al.
Cyhoeddwyd: (2012)